Minerva Neurosciences, Inc Stock Performance

Open $3.25	Prev. Close $3.25	Circuit Range N/A
Day Range $3.13 - $3.29	Year Range $2.43 - $12.28	Volume 14,626
Average Traded $3.19

Minerva Neurosciences, Inc Share Price Today

As of 11 October 2026, Minerva Neurosciences, Inc's share price is $3.16. The stock opened at $3.25, compared to its previous close of $3.25. During today's trading session, Minerva Neurosciences, Inc's share price traded between $3.13 and $3.29, with an average price of $3.21. Over the past 52 weeks, the stock has recorded a high of $12.28 and a low of $2.43. In terms of performance, Minerva Neurosciences, Inc's share price has declined by 50.93% over the last six months and is down 25.03% on a year-on-year basis.

Minerva Neurosciences, Inc Share Price Chart

$3.13$3.29

Minerva Neurosciences, Inc Stock Fundamentals & Key Indicators

Market Cap $26.74M	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-8.28	Revenue (TTM) $0.00	Return On Equity (TTM) 185.26%
Profit Margin N/A	Debt to Equity 0.00	Quarterly Earnings Growth YoY 707.66%

Minerva Neurosciences, Inc Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$2.74	-$283.67	-$125.40	$16.65
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	-10252.92%	55.79%	113.28%

Minerva Neurosciences, Inc Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$32.11	-$30.01	$1.44	-$293.42
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	6.54%	104.80%	-20476.39%

About Minerva Neurosciences, Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Minerva Neurosciences, Inc Historical Returns

Month	Open	Close	Change %
Oct 2026	$3.28	$3.17	-5.08%
Sep 2026	$4.58	$3.35	-34.92%
Aug 2026	$4.04	$5.14	+29.47%
Jul 2026	$5.43	$3.97	-28.73%
Jun 2026	$4.92	$5.57	+12.98%
May 2026	$6.38	$4.93	-23.45%
Apr 2026	$6.16	$6.44	+6.36%
Mar 2026	$6.23	$6.05	-8.05%
Feb 2026	$4.20	$6.58	+57.91%
Jan 2026	$4.01	$4.17	+0.97%
Dec 2025	$4.17	$4.13	+7.55%
Nov 2025	$3.99	$3.84	-8.90%

NERV Share Price FAQs

What is Minerva Neurosciences, Inc share price today?

Minerva Neurosciences, Inc share price today is $3.16 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Minerva Neurosciences, Inc stock?

The 52 week high of Minerva Neurosciences, Inc stock is $12.28, while the 52 week low is $2.43 as of 10 Oct '26.

What is NERV's market capitalisation today?

NERV market capitalisation is $26.74M as of October 11, 2026, at 2:05 am IST.

What is NERV's net income for the last quarter?

NERV's net income for the last quarter is 16.65B USD.

What is the 5 year returns of NERV?

The 5 year returns of NERV is -71.79% as on 10 Oct '26.

What is the high & low stock price of NERV today?

NERV stock price hit a high of $3.29 and low of $3.13 as of 10 Oct '26.

Can I buy NERV shares in India?

Yes. You can buy NERV in India by opening an international trading account.